Bothell, WA -- April 12, 2006 -- MedManage Systems Inc., the leading provider of online prescription drug sampling solutions, today announced it has received $10.75 million in Series D Preferred funding. The new round was led by QuestMark Partners, a Baltimore-based venture capital firm investing in emerging growth companies. Existing investors Versant Ventures, Lilly Ventures and Prism Venture Partners also joined the round. The capital will be used primarily for market expansion of the company’s Intelligent Sampling [sm] solutions, which are used by a growing list of major pharmaceutical manufacturers to improve commercial productivity and brand revenue by expanding drug sampling reach and frequency.
